HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pietro Amodeo Selected Research

2,5-dioxopiperazine

1/2016Correction to Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.
1/2016Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pietro Amodeo Research Topics

Disease

5Neoplasms (Cancer)
12/2020 - 01/2013
3Pain (Aches)
08/2021 - 09/2002
3Epilepsy (Aura)
05/2021 - 06/2007
3Inflammation (Inflammations)
02/2021 - 04/2006
2Substance-Related Disorders (Drug Abuse)
05/2021 - 01/2021
2Hyperalgesia
02/2021 - 01/2021
2Neuralgia (Stump Neuralgia)
02/2021 - 01/2021
2Neoplasm Metastasis (Metastasis)
12/2020 - 01/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
02/2019 - 10/2016
2Melanoma (Melanoma, Malignant)
01/2019 - 01/2013
2Weight Loss (Weight Reduction)
06/2011 - 06/2007
1Schizophrenia (Dementia Praecox)
05/2021
1Cytokine Release Syndrome
02/2021
1Chronic Disease (Chronic Diseases)
02/2021
1Keratitis
02/2021
1Peripheral Nervous System Diseases (PNS Diseases)
02/2021
1Peripheral Nerve Injuries
01/2021
1Chronic Pain
01/2021
1Cognitive Dysfunction
01/2021
1Neurobehavioral Manifestations
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Respiratory Tract Diseases (Respiratory Tract Disease)
10/2020
1Infections
10/2020
1Mood Disorders (Mood Disorder)
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Dyslipidemias (Dyslipidemia)
01/2019
1Pathological Protein Aggregation
01/2018
1Amyloidosis
01/2018
1Nervous System Diseases (Neurological Disorders)
10/2016
1Alexander Disease (Alexander's Disease)
10/2016
1Diabetes Complications
06/2014
1Diabetes Mellitus
06/2014
1HIV Infections (HIV Infection)
12/2013
1Rheumatoid Arthritis
12/2013
1Osteosarcoma (Osteogenic Sarcoma)
01/2013
1Kidney Neoplasms (Kidney Cancer)
01/2013
1Hematologic Neoplasms (Hematological Malignancy)
01/2013
1Bacterial Infections (Bacterial Infection)
04/2006
1Sarcoma (Soft Tissue Sarcoma)
02/2004
1Carcinoma (Carcinomatosis)
04/2003

Drug/Important Bio-Agent (IBA)

2CannabidiolIBA
05/2021 - 01/2021
2CytokinesIBA
02/2021 - 04/2006
2LigandsIBA
01/2021 - 12/2013
2Chemokine ReceptorsIBA
12/2020 - 12/2013
2Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2018 - 10/2016
2SynucleinsIBA
01/2018 - 10/2016
2Urea (Carbamide)FDA LinkGeneric
01/2016 - 01/2016
21,2,3,4-tetrahydroisoquinolineIBA
01/2016 - 01/2016
22,5-dioxopiperazineIBA
01/2016 - 01/2016
2Antineoplastic Agents (Antineoplastics)IBA
01/2013 - 02/2004
2Peptides (Polypeptides)IBA
01/2013 - 02/2004
1Dimenhydrinate (DMH)FDA LinkGeneric
08/2021
1EndocannabinoidsIBA
05/2021
1Prostaglandins AIBA
02/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
02/2021
1Formaldehyde (Formol)FDA Link
02/2021
1Glucosamine (Dona)IBA
02/2021
1GlycolipidsIBA
02/2021
1NF-kappa B (NF-kB)IBA
02/2021
1Lipid AIBA
02/2021
1MonosaccharidesIBA
02/2021
1Histamine (Histamine Dihydrochloride)FDA Link
01/2021
1Dopamine (Intropin)FDA LinkGeneric
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1OrexinsIBA
01/2021
1gamma-Aminobutyric Acid (GABA)IBA
01/2021
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2021
1Orexin ReceptorsIBA
01/2021
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2021
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2021
12-pentadecyl-2-oxazolineIBA
01/2021
1Transient Receptor Potential ChannelsIBA
10/2020
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
02/2019
1Biological ProductsIBA
01/2019
1Polychlorinated Biphenyls (PCBs)IBA
01/2019
1amidaseIBA
01/2019
1Muramidase (Lysozyme)IBA
01/2018
1Oxidopamine (6 Hydroxydopamine)IBA
10/2016
1LactamsIBA
10/2016
1Proteins (Proteins, Gene)FDA Link
10/2016
1Phenytoin (Dilantin)FDA LinkGeneric
10/2016
1Anti-Bacterial Agents (Antibiotics)IBA
10/2016
1EnzymesIBA
06/2014
1Aldehyde Reductase (Aldose Reductase)IBA
06/2014
1PectinsIBA
06/2011
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
06/2007
1Anticonvulsants (Antiepileptic Drugs)IBA
06/2007
1IsoenzymesIBA
06/2007
1LipidsIBA
06/2007
1Zonisamide (Zonegran)FDA LinkGeneric
06/2007
1Topiramate (Topamax)FDA LinkGeneric
06/2007
1ChemokinesIBA
04/2006
1Proline (L-Proline)FDA Link
02/2004
1aminoacylase I (aminoacylase)IBA
04/2003
1Amino AcidsFDA Link
04/2003
1Metalloproteases (Metalloproteinases)IBA
04/2003
1ZincIBA
04/2003

Therapy/Procedure

1Hematopoietic Stem Cell Mobilization
01/2013
1Autologous Transplantation
01/2013